Tilray Inc. (TLRY) saw its shares surge 5.02% in pre-market trading on Wednesday, continuing a strong rally for the cannabis producer. This follows an impressive 27.5% gain on Tuesday, as the stock benefits from renewed optimism in the sector.

The rally comes after President Donald Trump said he is "very strongly" considering reclassifying cannabis from a Schedule I to a Schedule III controlled substance. Such a move would reduce regulatory burdens and allow cannabis companies to deduct business expenses from taxes, potentially saving them millions annually. Trump's comments have sparked a broad rally across cannabis stocks, with Tilray emerging as one of the biggest beneficiaries.

Analysts note that rescheduling could pave the way for further reforms, including easier access to banking services and potential listings on major U.S. exchanges. While the process faces hurdles, the market is reacting positively to the prospect of reduced federal restrictions on the cannabis industry.